Skip navigation
MOST POPULAR RELATED TAGS
  • TOPICS
  • SECTORS
  • COMPANIES

MAD MONEY FEATURES

Podcasts PODCASTS
Watch the Lightning Round whenever and wherever you want.




Widget OFFICIAL MAD MONEY WIDGET
Grab this all-in-one application and get recaps of the show sent right to your desktop or blog.




Soundboard CRAMERS SOUNDBOARD
Admit it: You've always wanted to hit the "They
know nothing!" button. Here’s your chance.




Mad Money PhotosCHECK OUT OUR PHOTOS
Check out Cramer on set, back to school, behind the scenes and more.




ShopSHOP FOR MAD MERCHANDISE
Buy Cramer books, bobbleheads and other Mad Money merchandise.




Ringtones RING TONES
Pick up the phone! It's Cramer! New Mad Money sounds for your cell phone.




Mobile AlertTEXT MESSAGE ALERT
Mad Money's mobile. Get show highlights sent to your phone.







Text Size
Aug.25
7:48 PM ET
Monday, 25 Aug 2008
Is Allscripts a Buy?

We already talked about what a great push the folks in Washington can be for a company, and Allscripts is a similar play.

No, there isn’t one particular politician that bought this stock the way Nancy Pelosi bought Clean Energy Fuels [CLNE  Loading...      ()   ]. Allscripts [MDRX  Loading...      ()   ] benefits thanks to what Chairman and CEO Glenn Tullman called “landmark legislation,” the newly signed Medicare bill.

Washington has decided to pay doctors to use Allscripts e-prescribing software for drug prescriptions. And on top of that, the government will start to penalize doctors who aren’t using e-prescribing systems, starting in a few years.

“So you can’t ask for a better endorsement than the government actually pushing your product,” Tullman said.

The CEO also took a minute to explain the expected acquisition of Mysis Healthcare Systems, saying the deal is on track for completion and that shareholders can expect about $5 a share cash dividend once the merger is closed.

Cramer expressed some concern about the stock dropping once that payout happens, but Tullman said that was inevitable given that some stockholders only bought MDRX for that dividend. “If you believe in the long-term premise,” he said, then that dip is a buying opportunity.

“This is a good story,” Cramer said. If the stock gets hit on the dividend payout, he might recommend MDRX again.



Questions for Cramer?

Questions, comments, suggestions for the Mad Money website?

© 2009 CNBC, Inc. All Rights Reserved

Tools:
PrintEmailAdd This share icon
  • digg share
ADD COMMENTS
Remaining characters


Current DateTime: 01:03:48 15 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 01:02:04 15 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 01:02:04 15 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 01:02:04 15 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters